Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Skin Microbiome Change in Atopic Dermatitis with Crisaborole
NCT04800185Phase 1Completed
- Sponsor
- University of California, Irvine
- Start
- Mar 2021
- Primary completion
- Apr 2022
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of AN2728 ointment vehicle in atopic dermatitis (AD), sponsored by University of California, Irvine. Primary endpoint: Change in skin microbiome taxonomic units at 16 weeks. Started Mar 2021; status: completed.
02
Drugs
AN2728 ointment vehicle
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT04800185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04800185.